Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Sibling Capital

Founders Sandra Coufal

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 6
Average round size
info
The average size of a deal this fund participated in
$49M
Portfolio companies 2
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.67
Exits 2
Key employees 1
Stages of investment
Early Stage Venture
Private Equity

Areas of investment

  • Health Care
  • Pharmaceutical
  • Medical
  • Biopharma
  • Biotechnology
Summary

The leading representative office of defined VC is situated in the Rancho Santa Fe. The venture was found in North America in United States.

The usual cause for the fund is to invest in rounds with 5-6 partakers. Despite the Sibling Capital, startups are often financed by OrbiMed, Sprout Group, New Leaf Venture Partners. The meaningful sponsors for the fund in investment in the same round are OrbiMed, Limulus Venture Partners, Vivo Capital. In the next rounds fund is usually obtained by OrbiMed, Limulus Venture Partners, Vivo Capital.

The usual things for fund are deals in the range of 10 - 50 millions dollars. The higher amount of exits for fund were in 2018. This Sibling Capital works on 4 percentage points more the average amount of lead investments comparing to the other organizations. The top activity for fund was in 2012. The fund is constantly included in less than 2 deals per year.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. Among the most successful fund investment fields, there are Biotechnology, Pharmaceutical. Among the most popular portfolio startups of the fund, we may highlight Relypsa, Tricida.

The fund was created by Sandra Coufal. The overall number of key employees were 1.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Sibling Capital:
Typical Co-investors
Sibling Capital is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Sibling Capital:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Aota Touzi China, Guangdong, Shenzhen
Blue Horizon Corporation Switzerland, Zürich, Zurich
Cap-Meridian Ventures New York, New York, United States
Chiba Dojo Japan, Tokyo
Devenish Nutrition Fairmont, Minnesota, United States
Dollar General Goodlettsville, Tennessee, United States
Early Capital -
Gordon Food Service Grand Rapids, Michigan, United States
GP Healthcare Capital China, Shanghai
Himachal Futuristic Communications Limited -
IIX Asia Central, Central Region, Singapore
Jinyuan Development Company -
Ojai Goliad Dallas, Texas, United States
Purify -
Qingdao Chuban Touzi Youxian Gongsi China, Qingdao Shi, Shandong
SDIC Venture Capital China, Hebei, Xicheng
Seed Fond Aachen Aachen, Germany, Nordrhein-Westfalen
VCF III -
VivaKi Chicago, Illinois, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Tricida

Health Care
Medical
Pharmaceutical
$55M25 Jul 2016 California, United States

Tricida

Health Care
Medical
Pharmaceutical
$30M04 Mar 2015 California, United States

Tricida

Health Care
Medical
Pharmaceutical
$10M04 Sep 2014 California, United States

Relypsa

Biopharma
Biotechnology
Health Care
$80M14 Aug 2012 Redwood City, California, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Sibling Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 6
Average round size 49M
Peak activity year 2012
Lead investments 0
Follow on index 0.67
Exits 2
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Tricida

Health Care
Medical
Pharmaceutical
$55M25 Jul 2016 California, United States

Tricida

Health Care
Medical
Pharmaceutical
$30M04 Mar 2015 California, United States

Tricida

Health Care
Medical
Pharmaceutical
$10M04 Sep 2014 California, United States

Relypsa

Biopharma
Biotechnology
Health Care
$80M14 Aug 2012 Redwood City, California, United States
Crunchbase icon

Content report

The following text will be sent to our editors: